Aspira Women's Health Full Year 2022 Earnings: EPS Beats Expectations

·1 min read

Aspira Women's Health (NASDAQ:AWH) Full Year 2022 Results

Key Financial Results

  • Revenue: US$8.18m (up 20% from FY 2021).

  • Net loss: US$27.2m (loss narrowed by 14% from FY 2021).

  • US$0.23 loss per share (improved from US$0.28 loss in FY 2021).


All figures shown in the chart above are for the trailing 12 month (TTM) period

Aspira Women's Health EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 19%.

Looking ahead, revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 4.8% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 5 warning signs for Aspira Women's Health (2 are concerning!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here